ID

12910

Description

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes; ODM derived from: https://clinicaltrials.gov/show/NCT00329498

Link

https://clinicaltrials.gov/show/NCT00329498

Keywords

  1. 1/6/16 1/6/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 6, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Myeloid Leukemia NCT00329498

Eligibility Acute Myeloid Leukemia NCT00329498

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients should have aml or mds according to new who classification, with minimum of 5% blasts in peripheral blood.
Description

AML or MDS

Data type

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C3463824
there must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
Description

Treatment history

Data type

boolean

Alias
UMLS CUI [1]
C0087111
prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
Description

Prior treatment

Data type

boolean

Alias
UMLS CUI [1]
C0087111
adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
Description

Bone marrow

Data type

boolean

Alias
UMLS CUI [1]
C0005953
there are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. although aml is rare in children, pediatric patients will be accepted.
Description

Further restrictions

Data type

boolean

Alias
UMLS CUI [1]
C0700589
there is no deficiency of g6pd (rbc).
Description

Deficiency of g6pd

Data type

boolean

Alias
UMLS CUI [1]
C0391941
asymptomatic patients with disease progression and symptomatic patients.
Description

Disease characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0242656
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251

Similar models

Eligibility Acute Myeloid Leukemia NCT00329498

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
AML or MDS
Item
patients should have aml or mds according to new who classification, with minimum of 5% blasts in peripheral blood.
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
Treatment history
Item
there must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
boolean
C0087111 (UMLS CUI [1])
Prior treatment
Item
prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
boolean
C0087111 (UMLS CUI [1])
Bone marrow
Item
adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
boolean
C0005953 (UMLS CUI [1])
Further restrictions
Item
there are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. although aml is rare in children, pediatric patients will be accepted.
boolean
C0700589 (UMLS CUI [1])
Deficiency of g6pd
Item
there is no deficiency of g6pd (rbc).
boolean
C0391941 (UMLS CUI [1])
Disease characteristics
Item
asymptomatic patients with disease progression and symptomatic patients.
boolean
C0242656 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial